MUC2 gene promoter methylation in mucinous and non-mucinous colorectal cancer tissues

International Journal of Oncology

Volumn 36, Issue 4, 2010, Pages 765-775

  Okudaira, Keisuke ^a,b   Kakar, Sanjay ^a   Cun, Lisa ^a   Choi, Ester ^a   Decamillis, Rina Wu ^c   Miura, Soichiro ^b   Sleisenger, Marvin H ^a   Kim, Young S ^a   Deng, Gouren ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c Genemed Biotechnologies Inc   (United States)

Author keywords

DNA methylation; MUC2; Mucinous colorectal cancer

Indexed keywords

MUCIN 2;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; COLORECTAL CANCER; FEMALE; GENE LOSS; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METHYLATION; MUCINOUS CANCER TISSUE; NON MUCINOUS CANCER TISSUE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TISSUE DIFFERENTIATION;

ADENOCARCINOMA, MUCINOUS; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUCIN-2; NEOPLASM STAGING; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77749333040     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000552     Document Type: Article

References (43)

1. Secco GB, Fardelli R, Campora E, Lapertosa G, Gentile R, Zoli S and Prior C: Primary mucinous adenocarcinomas and signetring cell carcinomas of colon and rectum. Oncology 51: 30-34, 1994.
2. Green JB, Timmcke AE, Mitchell WT, Hicks TC, Gathright JB Jr and Ray JE: Mucinous carcinoma-just another colon cancer? Dis Colon Rectum 36: 49-54, 1993.
3. Zhang H, Evertsson S and Sun X: Clinicopathological and genetic characteristics of mucinous carcinomas in the colorectum. Int J Oncol 14: 1057-1061, 1999.
4. Nozoe T, Anai H, Nasu S and Sugimachi K: Clinicopathological characteristics of mucinous carcinoma of the colon and rectum. J Surg Oncol 75: 103-107, 2000.
5. Song GA, Deng G, Bell I, Kakar S, Sleisenger MH and Kim YS: Mucinous carcinomas of the colorectum have distinct molecular genetic characteristics. Int J Oncol 26: 745-750, 2005.
6. Kakar S, Aksoy S, Burgart LJ and Smyrk TC: Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survival. Mod Pathol 17: 696-700, 2004.
7. Hawkins N, Norrie M, Cheong K, Mokany E, Ku SL, Meagher A, O'Connor T and Ward R: CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 122: 1376-1387, 2002.
8. Nagasaka T, Sasamoto H, Notohara K, Cullings HM, Takeda M, Kimura K, Kambara T, MacPhee DG, Young J, Leggett BA, Jass JR, Tanaka N and Matsubara N: Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. J Clin Oncol 22: 4584-4594, 2004.
9. Tanaka H, Deng G, Matsuzaki K, Kakar S, Kim GE, Miura S, Sleisenger MH and Kim YS: BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer. Int J Cancer 118: 2765-2771, 2006.
10. Hanski C: Is mucinous carcinoma of the colorectum a distinct genetic entity? Br J Cancer 72: 1350-1356, 1995.
11. Li JD, Feng W, Gallup M, Kim JH, Gum J, Kim Y and Basbaum C: Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. Proc Natl Acad Sci USA 95: 5718-5723, 1998.
12. Enss ML, Cornberg M, Wagner S, Gebert A, Henrichs M, Eisenblatter R, Beil W, Kownatzki R and Hedrich HJ: Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180. Inflamm Res 49: 162-169, 2000.
13. Fischer BM, Rochelle LG, Voynow JA, Akley NJ and Adler KB: Tumor necrosis factor-alpha stimulates mucin secretion and cyclic GMP production by guinea pig tracheal epithelial cells in vitro. Am J Respir Cell Mol Biol 20: 413-422, 1999.
14. Dabbagh K, Takeyama K, Lee HM, Ueki IF, Lausier JA and Nadel JA: IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J Immunol 162: 6233-6237, 1999.
15. Levine SJ, Larivee P, Logun C, Angus CW, Ognibene FP and Shelhamer JH: Tumor necrosis factor-alpha induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cells. Am J Respir Cell Mol Biol 12: 196-204, 1995.
16. Shim JJ, Dabbagh K, Ueki IF, Dao-Pick T, Burgel PR, Takeyama K, Tam DC and Nadel JA: IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. Am J Physiol Lung Cell Mol Physiol 280: L134-L140, 2001.
17. Yoon JH, Kim KS, Kim HU, Linton JA and Lee JG: Effects of TNF-alpha and IL-1 beta on mucin, lysozyme, IL-6 and IL-8 in passage-2 normal human nasal epithelial cells. Acta Otolaryngol 119: 905-910, 1999.
18. Nadel JA: Role of epidermal growth factor receptor activation in regulating mucin synthesis. Respir Res 2: 85-89, 2001.
19. Perrais M, Pigny P, Copin MC, Aubert JP and Van Seuningen I: Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor/Ras/Raf/extracellular signal-regulated kinase cascade and Sp1. J Biol Chem 277: 32258-32267, 2002.
20. Takeyama K, Dabbagh K, Lee HM, Agusti C, Lausier JA, Ueki IF, Grattan KM and Nadel JA: Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci USA 96: 3081-3086, 1999.
21. Jono H, Shuto T, Xu H, Kai H, Lim DJ, Gum JR Jr, Kim YS, Yamaoka S, Feng XH and Li JD: Transforming growth factor-beta -Smad signaling pathway cooperates with NF-kappa B to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription. J Biol Chem 277: 45547-45557, 2002.
22. Lee HW, Ahn DH, Crawley SC, Li JD, Gum JR Jr, Basbaum CB, Fan NQ, Szymkowski DE, Han SY, Lee BH, Sleisenger MH and Kim YS: Phorbol 12-myristate 13-acetate up-regulates the transcription of MUC2 intestinal mucin via Ras, ERK, and NF-kappa B. J Biol Chem 277: 32624-32631, 2002.
23. Koo JS, Yoon JH, Gray T, Norford D, Jetten AM and Nettesheim P: Restoration of the mucous phenotype by retinoic acid in retinoid-deficient human bronchial cell cultures: changes in mucin gene expression. Am J Respir Cell Mol Biol 20: 43-52, 1999.
24. Gum JR, Hicks JW and Kim YS: Identification and characterization of the MUC2 (human intestinal mucin) gene 5′-flanking region: promoter activity in cultured cells. Biochem J 325: 259-267, 1997.
25. Ookawa K, Kudo T, Aizawa S, Saito H and Tsuchida S: Transcriptional activation of the MUC2 gene by p53. J Biol Chem 277: 48270-48275, 2002.
26. Yamamoto H, Bai YQ and Yuasa Y: Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression. Biochem Biophys Res Commun 300: 813-818, 2003.
27. Park ET, Oh HK, Gum JR Jr, Crawley SC, Kakar S, Engel J, Leow CC, Gao WQ and Kim YS: HATH1 expression in mucinous cancers of the colorectum and related lesions. Clin Cancer Res 12: 5403-5410, 2006.
28. Siedow A, Szyf M, Gratchev A, Kobalz U, Hanski ML, Bumke-Vogt C, Foss HD, Riecken EO and Hanski C: De novo expression of the Muc2 gene in pancreas carcinoma cells is triggered by promoter demethylation. Tumour Biol 23: 54-60, 2002.
29. Ho JJ, Han SW, Pan PL, Deng G, Kuan SF and Kim YS: Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells. Int J Oncol 22: 273-279, 2003.
30. Hanski C, Riede E, Gratchev A, Foss HD, Bohm C, Klussmann E, Hummel M, Mann B, Buhr HJ, Stein H, Kim YS, Gum J and Riecken EO: MUC2 gene suppression in human colorectal carcinomas and their metastases: in vitro evidence of the modulatory role of DNA methylation. Lab Invest 77: 685-695, 1997.
31. Riede E, Gratchev A, Foss HD, Mann B, Buhr HJ and Hanski C: Increased methylation of promotor region suppresses expression of MUC2 gene in colon carcinoma cells. Langenbecks Arch Chir (Suppl Kongressbd) 115: 299-302, 1998.
32. Gratchev A, Siedow A, Bumke-Vogt C, Hummel M, Foss HD, Hanski ML, Kobalz U, Mann B, Lammert H, Mansmann U, Stein H, Riecken EO and Hanski C: Regulation of the intestinal mucin MUC2 gene expression in vivo: evidence for the role of promoter methylation. Cancer Lett 168: 71-80, 2001.
33. Hamada T, Goto M, Tsutsumida H, Nomoto M, Higashi M, Sugai T, Nakamura S and Yonezawa S: Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing. Cancer Lett 227: 175-184, 2005.
34. Yamada N, Hamada T, Goto M, Tsutsumida H, Higashi M, Nomoto M and Yonezawa S: MUC2 expression is regulated by histone H3 modification and DNA methylation in pancreatic cancer. Int J Cancer 119: 1850-1857, 2006.
35. Schoeppner HL, Raz A, Ho SB and Bresalier RS: Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer 75: 2818-2826, 1995.
36. Ho SB, Ewing SL, Montgomery CK and Kim YS: Altered mucin core peptide immunoreactivity in the colon polypcarcinoma sequence. Oncol Res 8: 53-61, 1996.
37. Mesquita P, Peixoto AJ, Seruca R, Hanski C, Almeida R, Silva F, Reis C and David L: Role of site-specific promoter hypomethylation in aberrant MUC2 mucin expression in mucinous gastric carcinomas. Cancer Lett 189: 129-136, 2003.
38. Deng G, Chen A, Hong J, Chae HS and Kim YS: Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res 59: 2029-2033, 1999.
39. Leow CC, Romero MS, Ross S, Polakis P and Gao WQ: Hath1, down-regulated in colon adenocarcinomas, inhibits proliferation and tumorigenesis of colon cancer cells. Cancer Res 64: 6050-6057, 2004.
40. Yonezawa S, Nakamura A, Horinouchi M and Sato E: The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. J Hepatobiliary Pancreat Surg 9: 328-341, 2002.
41. Adsay NV, Merati K, Andea A, Sarkar F, Hruban RH, Wilentz RE, Goggins M, Iocobuzio-Donahue C, Longnecker DS and Klimstra DS: The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol 15: 1087-1095, 2002.
42. Mesquita P, Jonckheere N, Almeida R, Ducourouble MP, Serpa J, Silva E, Pigny P, Silva FS, Reis C, Silberg D, Van Seuningen I and David L: Human MUC2 mucin gene is transcriptionally regulated by Cdx homeodomain proteins in gastrointestinal carcinoma cell lines. J Biol Chem 278: 51549-51556, 2003.
43. Kawai H, Tomii K, Toyooka S, Yano M, Murakami M, Tsukuda K and Shimizu N: Promoter methylation down-regulates CDX2 expression in colorectal carcinomas. Oncol Rep 13: 547-551, 2005.